Hubei Goto Biopharm Co.,Ltd. (300966.SZ) SHZ
26.66
-0.38(-1.41%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Hubei Goto Biopharm Co.,Ltd.
Address
Group 1 Gaokeng
Yicheng, 441400
China
Phone
86 71 0342 3122
Sector
Healthcare
Industry
Biotechnology
Employees
631
First IPO Date
April 09, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Zubin Xi | Chairman of the Board, GM, & Research and Development Director | 0 | 1970 |
| Minglei Li | Non Independent Director & Deputy GM | 0 | 1977 |
| Xiangdong Liu | Chief Financial Officer, Head of Accounting Agency & Non-Independent Director | 0 | 1974 |
| Wenjing Chen | Board Secretary & Deputy GM | 0 | 1973 |
Description
Hubei Goto Biopharm Co.,Ltd. engages in the production and sale of steroid hormone API's and intermediates in China. It offers starting materials, such as 9a-hydroxy-4-androstenedione(9a-OHAD), bisnoralcohol(BA), sitolactone, 1.4-androstadienedione(ADD), and 4-androstenedione(4-AD); intermediates, including estrogens, progesterone, nonsteroids, other hormones, and corticosteroids; and other pharmaceutical raw materials. The company was founded in 2006 and is based in Yicheng, China.
